Drug Trial Radar · NCT04882098
A Study of Guselkumab in Participants With Active Psoriatic Arthritis
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,054
Actual
Start
Jun 17, 2021
Primary completion
Dec 30, 2024
Study completion Oct 6, 2027
Sponsor
- Lead sponsor
- Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
- Sponsor type
- Industry
- First posted
- May 11, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) by assessing the reduction in signs and symptoms of PsA.
Conditions
- Arthritis, Psoriatic
Interventions
GuselkumabDrug
Participants will receive guselkumab as SC injection.
PlaceboDrug
Participants will receive matching placebo as SC injection.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Achieved an American College of Rheumatology (ACR) 20 Response at Week 24Time frame: At Week 24
Locations
280 sites in 29 countries. Site status is shown where the registry gives one.
Rheumatology Associates
Birmingham, Alabama
Arizona Arthritis and Rheumatology Research PLLC
Flagstaff, Arizona
Arizona Arthritis & Rheumatology Associates PC
Glendale, Arizona
Arizona Arthritis & Rheumatology Research, PLLC
Tucson, Arizona
Advanced Medical Research
La Palma, California
Rheumatology Center of San Diego
San Diego, California
Medvin Clinical Research, Inc.
Whittier, California
Heuer M.D. Research
Orlando, Florida
The Arthritis Center, Inc.
Palm Harbor, Florida
Forcare Clinical Research Inc
Tampa, Florida
Klein And Associates M D P A
Hagerstown, Maryland
Advanced Rheumatology
Okemos, Michigan
Arthritis Consultants
St Louis, Missouri
Glacier View Research Institute
Kalispell, Montana
NYU Langone Ambulatory Care Brooklyn Heights
Brooklyn, New York
PMG Research of Salisbury
Salisbury, North Carolina
STAT Research, Inc.
Springboro, Ohio
Altoona Center For Clinical Research
Duncansville, Pennsylvania
Dr. Ramesh Gupta
Memphis, Tennessee
Austin Regional Clinic
Austin, Texas
Adriana Pop Moody MD Clinic PA
Corpus Christi, Texas
Southwest Rheumatology Research LLC
Mesquite, Texas
Arthritis And Osteoporosis Clinic
Waco, Texas
The Queen Elizabeth Hospital
Adelaide, Australia
Southern Clinical Research
Hobart, Australia
Emeritus Research
Melbourne, Australia
Eastern Health - Box Hill Hospital
Melbourne, Australia
Rheumatology Research Unit
Sunshine Coast, Australia
University Clinical center Republic of Srpska 1
Banja Luka, Bosnia and Herzegovina
University Clinical center Republic of Srpska
Banja Luka, Bosnia and Herzegovina
Health center Gradiska
Gradiska, Bosnia and Herzegovina
Clinical hospital Mostar
Mostar, Bosnia and Herzegovina
Clinical Center University of Sarajevo
Sarajevo, Bosnia and Herzegovina
Medical Center Medconsult-Pleven
Pleven, Bulgaria
Multiprofile Hosptal for Active Treatment Eurohospital Plovdiv
Plovdiv, Bulgaria
UMHAT Kaspela 1
Plovdiv, Bulgaria
UMHAT Kaspela
Plovdiv, Bulgaria
MHAT Trimantium
Plovdiv, Bulgaria
Multiprofile Hospital for Active Treatment Plovdiv
Plovdiv, Bulgaria
Medical Center Unimed Plovdiv
Plovdiv, Bulgaria
Showing 40 of 280 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.